<unk> (intravitreal implant) is a corticosteroid that is FDA approved for the treatment of diabetic macular edema in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure.   Common adverse reactions include cataract, myodesopsia, eye pain, conjunctival hemorrhage, posterior capsule opacification, eye irritation, conjunctivitis, ocular hyperaemia, foreign body sensation in eyes, corneal oedema and 		headache.
Fluocinolone acetonide 
Fluocinonide
Amcinonide
Ciclesonide 
Triamcinolone acetonide 
Triamcinolone acetonide
Desonide
Halcinonide